WILLIAMSTOWN, MASS. ( TheStreet.com) -- Morgan Stanley ( MS) ( MS) Smith Barney is the latest firm to put the kibosh on leveraged ETFs. The wealth management division has noted that it will be making three major changes concerning the use of leveraged ETF products.First, the firm will no longer solicit purchases of leveraged and inverse ETF products in traditional brokerage accounts. Second, advisory accounts will not be allowed to purchase leveraged funds. Finally, customer-driven purchases of leveraged ETF products will be more highly regulated. Morgan Stanley Smith Barney's move to restrict leveraged ETFs comes in the wake of a widespread controversy surrounding the non-traditional funds. Edward Jones and UBS ( UBS) were two of the first firms to curb the products with firms like Ameriprise ( AMP) following soon after. The Financial Industry Regulatory Authority's (FINRA) recent concern over the use of leveraged ETFs helped to spark the onslaught. In June, FINRA released a notice asserting that leveraged ETFs are "typically not suitable" for retail investors planning to invest for more than one day. FINRA later softened its statement by allowing that leveraged ETFs can be appropriate for short-term investors whose strategies are "closely monitored" by financial professionals. Regulatory scrutiny has already proven to be a blow to the funds. Leveraged ETFs had net outflows of $1.56 billion in July, a strong reversal after a $1.8 billion gain the previous month, according to TrimTabs Investment Research. In the first seven months of 2009, leveraged ETFs attracted more than $7 billion. Leveraged fund issuers like Direxion, ProShares and Rydex have responded to the regulatory squeeze by increasing disclosure on their websites and advertising. Direxion, creator of highly popular funds like Daily Financial Bull 3X ( FAS), Daily Financial Bear ( FAZ), Daily Emerging Markets Bull 3X ( EDC) and Daily Emerging Markets Bear 3X ( EDZ), has extensive disclaimers on its website.
"The ETFs are not suitable for all investors and should be utilized only by sophisticated investors who understand leverage risk, consequences of seeking daily leveraged investment results and intend to actively monitor and manage their investments," notes the disclosure at the bottom of Direxion's online product list. "The Funds are not designed to track the underlying index over a longer period of time." Direxion is also combating the outflow through diversification. The fund recently filed to premier a 130/30 hedge-fund strategy ETF, similar to the ProShares Credit Suisse 130/30 ETF ( CSM). This sophisticated strategy will employ leverage in both directions, but will be likely aimed at a longer-term horizon for investors. The sophistication of many nontraditional ETF strategies, like leveraged ETFs and futures-based commodity ETFs, takes away from the transparency that many investors expect from ETF investments. While these funds are hedge-able by large profitable trading divisions at firms like Goldman Sachs ( GS), it is difficult for retail investors to hedge with the underlying investments in these funds. The Commodities Futures Trading Commission is attacking the problem from one side while FINRA routs out the problem from the other. While the issue for the former is commodities ETFs and for the latter leveraged ETFs, futures and swaps are the issue in both cases. The CFTC, FINRA and SEC should join forces to regulate the use of these products, rather than launching separate campaigns. ETF issuers have used futures and swaps to enhance, and complicate, investment vehicles known for transparency and accessibility. While these funds are appropriate for sophisticated investors, traders in these funds should be identified as such before purchasing shares. A coordinated effort on the part of these agencies would be beneficial for the ETF consumer in the long haul. A reclassification of traditional and non-traditional ETF products and an examination of sales procedures would help to protect consumers while allowing the ETF industry to grow. -- written by Don Dion in Williamstown, Mass.